Skip to main content

Peer Review reports

From: Comparison of ICS dose reduction vs. montelukast discontinuation for step-down therapy in well-controlled asthma: a pilot randomized controlled trial

Original Submission
19 Jul 2024 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
12 Aug 2024 Author responded Author comments - Hamidreza Abtahi
Resubmission - Version 3
12 Aug 2024 Submitted Manuscript version 3
13 Aug 2024 Author responded Author comments - Hamidreza Abtahi
Resubmission - Version 4
13 Aug 2024 Submitted Manuscript version 4
18 Aug 2024 Reviewed Reviewer Report
20 Aug 2024 Reviewed Reviewer Report
22 Aug 2024 Reviewed Reviewer Report
4 Sep 2024 Author responded Author comments - Hamidreza Abtahi
Resubmission - Version 5
4 Sep 2024 Submitted Manuscript version 5
12 Sep 2024 Reviewed Reviewer Report
16 Sep 2024 Reviewed Reviewer Report
24 Sep 2024 Author responded Author comments - Hamidreza Abtahi
Resubmission - Version 6
24 Sep 2024 Submitted Manuscript version 6
2 Oct 2024 Author responded Author comments - Hamidreza Abtahi
Resubmission - Version 7
2 Oct 2024 Submitted Manuscript version 7
10 Oct 2024 Reviewed Reviewer Report - Luis J. Nannini
11 Nov 2024 Reviewed Reviewer Report
21 Nov 2024 Reviewed Reviewer Report
8 Dec 2024 Author responded Author comments - Hamidreza Abtahi
Resubmission - Version 8
8 Dec 2024 Submitted Manuscript version 8
11 Jan 2025 Reviewed Reviewer Report - Luis J. Nannini
13 Jan 2025 Reviewed Reviewer Report
13 Jan 2025 Reviewed Reviewer Report - Matthew A. Rank
30 Jan 2025 Author responded Author comments - Hamidreza Abtahi
Resubmission - Version 9
30 Jan 2025 Submitted Manuscript version 9
23 Mar 2025 Author responded Author comments - Hamidreza Abtahi
Resubmission - Version 10
23 Mar 2025 Submitted Manuscript version 10
Publishing
25 Mar 2025 Editorially accepted
9 Apr 2025 Article published 10.1186/s12890-025-03629-6

You can find further information about peer review here.

Back to article page